10 Stocks Fall Behind Amid Market Optimism

8. Aditxt Inc. (NASDAQ:ADTX)

Aditxt saw its share prices decline for a fourth straight day on Wednesday, shedding 8.81 percent to end at $3 apiece as investors sold off positions despite news that it had officially regained compliance with the Nasdaq’s minimum bid price requirement.

The Nasdaq invited ADTX for a hearing on April 22, 2025 to supposedly explain its non-compliance, but it has already been canceled after regaining the compliant status.

“We are pleased to have regained compliance with Nasdaq’s listing requirements. We continue to remain focused on advancing our progress towards addressing autoimmunity, cancer, and other pressing health challenges,” said ADTX co-founder and CEO Amro Albanna.

In other news, ADTX said it entered into a financial agreement with Evofem Biosciences for a $1.5-million investment in the latter in exchange for a convertible note and a warrant to acquire shares.

The investment was in line with the two companies’ planned merger strategy which has been in the works since March 23.